EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN

<em>The immunomodulating activity of pidotimod (imunorix) was evaluated in a doublebblind, placebobcontrolled, randomized, multicentre trial, on 120 pediatric patients affected by recurrent respiratory infections. Antibiotic therapy and time of hospitalization were shorter in the patients taki...

Full description

Bibliographic Details
Main Authors: G. Caramia, E. Clemente, R. Solli, V. Mei, R. Cera, V. Carnelli, V. Venturoli, A. Corsini
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2008-01-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/1371